1. Pershing Square, Valeant Arrive at Settlement Split for Allergan Lawsuit

    Pershing Square, Valeant Arrive at Settlement Split for Allergan Lawsuit

    Read (Reuters) - Activist investor William Ackman’s Pershing Square PHS.AS and Valeant Pharmaceuticals ( VRX.TO ) on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. We decided, however, that it was in the best interest of our investors to settle the case now instead of continuing to spend substantial time and resources pursuing the litigation.
    2. We believe this agreement to resolve the legacy litigation is in the best interests of the Company, because it enables us to focus our attention and resources on the transformation of Valeant.
  3. Topics Mentioned

  4. Authors